Almac Clinical Technologies announced today that its Testing Department has completed the ISTQB Software certification.
Almac Testers Receive ISTQB Software Testing Certification
2 July 2008 Yardley, Pennsylvania. Almac Clinical Technologies announced today that its Testing Department has completed the ISTQB Software certification. ISTQB (International Software Testing Qualification Board, Inc.) is the most widely recognized Software Tester certification organization in the world. Almac is one of the first clinical technology organizations to receive this certification. This training assures sponsors that Almac is continuously committed to providing the highest quality technical solutions for its clients.
The testers of Almac Clinical Technologies have been awarded the designation of Certified Tester, Foundation Level (CTFL). The Foundation Level exam tests for software testing knowledge and proficiency, as well the certificate holder's level of familiarity with software testing concepts and industry standard terminology. The Almac Clinical Technologies Testing Department is now part of an elite group of software testers throughout the world that currently hold ISTQB compliant certificates.
Karen Borda, Vice President of Production IT, says “Successfully completing the ISTQB certification for software testing sends another signal to our clients that Almac Clinical Technologies is committed to operational excellence, high-quality service performance, and providing compliant solutions in a timely manner. At Almac we take pride in working consultatively with our clients to understand their needs, gather their trial requirements, and provide innovative solutions for each trial. The ISTQB certification gives us a technological edge over our competitors and reinforces our industry-leading reputation for high quality products supported by our commitment to staff excellence. We aim to be a couple of notches above our competition and this certification supports that goal.”
Jim Murphy, President of Almac Clinical Technologies adds, “At Almac we realize that the power of technology is enhanced through superior project management, customer service and highly-trained employees. Given the technological challenges faced by our clients in the biopharmaceutical industry, Almac Clinical Technologies provides rigorous training for its employees, the ISTQB being just one of many programs we have completed to build our expertise in technology and project management.”
About Almac
Almac Clinical Technologies is a division of the Almac Group that specializes in interactive technology and service solutions to increase the quality and efficiency of the clinical trial process. Our solutions include Interactive Voice and Web Response Systems (IXRS™) for patient randomization; tracking and clinical supply management; iTrial EDC for electronic case report form data collection; electronic patient reported outcome data collection; and web drug reconciliation.
The Almac Group comprises five closely integrated divisions offering a broad range of services from R&D, translational genomic services, API manufacture, formulation development, clinical trial supply and technology (IVRS/EDC), to commercial-scale manufacture. Almac provides services to over 600 companies including all the world leaders in the pharmaceutical and biotech sectors. The company employs over 2,000 individuals and is headquartered in Craigavon, Northern Ireland. US operations are based in Pennsylvania, North Carolina and California.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.